| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |